{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:15:59Z","timestamp":1758273359960},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10,1]]},"DOI":"10.1093\/jac\/dki307","type":"journal-article","created":{"date-parts":[[2005,8,27]],"date-time":"2005-08-27T00:24:37Z","timestamp":1125102277000},"page":"726-731","source":"Crossref","is-referenced-by-count":16,"title":["Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice"],"prefix":"10.1093","volume":"56","author":[{"given":"Masood A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahseen H.","family":"Nasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Owais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,8,26]]},"reference":[{"key":"key\n\t\t\t\t20171010172403_B1","doi-asserted-by":"crossref","unstructured":"Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS\u2014100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev1995; 8: 515\u201348.","DOI":"10.1128\/CMR.8.4.515"},{"key":"key\n\t\t\t\t20171010172403_B2","doi-asserted-by":"crossref","unstructured":"Vilchez RA, Fung J, Kusne S. Cryptococcosis in organ transplant recipients: an overview. Am J Transplant2002; 2: 575\u201380.","DOI":"10.1034\/j.1600-6143.2002.20701.x"},{"key":"key\n\t\t\t\t20171010172403_B3","doi-asserted-by":"crossref","unstructured":"Krcmery V, Krupova I, Denning DW. Invasive yeast infections other than Candida spp. in acute leukaemia. J Hosp Infect1999; 41: 181\u201394.","DOI":"10.1016\/S0195-6701(99)90015-4"},{"key":"key\n\t\t\t\t20171010172403_B4","doi-asserted-by":"crossref","unstructured":"Yamaguchi H, Abe S, Tokuda Y. Immunomodulating activity of antifungal drugs. Ann N Y Acad Sci1993; 685: 447\u201357.","DOI":"10.1111\/j.1749-6632.1993.tb35905.x"},{"key":"key\n\t\t\t\t20171010172403_B5","doi-asserted-by":"crossref","unstructured":"Stevens DA. Combination immunotherapy and antifungal chemotherapy. Clin Infect Dis1998; 26: 1266\u20139.","DOI":"10.1086\/516362"},{"key":"key\n\t\t\t\t20171010172403_B6","doi-asserted-by":"crossref","unstructured":"Kullberg BJ. Trends in immunotherapy of fungal infections. Eur J Clin Microbiol Infect Dis1997; 16: 51\u20135.","DOI":"10.1007\/BF01575121"},{"key":"key\n\t\t\t\t20171010172403_B7","unstructured":"Roilides E, Dignani MC, Anaissie EJ et al. The role of immunoreconstitution in the management of refractory opportunistic fungal infections. Med Mycol1998; 36 Suppl 1: 12\u201325."},{"key":"key\n\t\t\t\t20171010172403_B8","doi-asserted-by":"crossref","unstructured":"Casadevall A, Pirofski L. Adjunctive immune therapy for fungal infections. Clin Infect Dis2001; 33: 1048\u201356.","DOI":"10.1086\/322710"},{"key":"key\n\t\t\t\t20171010172403_B9","doi-asserted-by":"crossref","unstructured":"Dutta RC, Puri A, Anand N. Immunomodulatory potential of hydrophobic analogs of Rigin and their role in providing protection against Plasmodium berghei infection in mice. Int Immunopharmacol2001; 1: 843\u201355.","DOI":"10.1016\/S1567-5769(01)00021-2"},{"key":"key\n\t\t\t\t20171010172403_B10","doi-asserted-by":"crossref","unstructured":"Khan MA, Faisal SM, Haque W et al. Immunomodulator tuftsin augments anti-fungal activity of amphotericin B against experimental murine candidiasis. J Drug Target2002; 10: 185\u201392.","DOI":"10.1080\/10611860290022615"},{"key":"key\n\t\t\t\t20171010172403_B11","doi-asserted-by":"crossref","unstructured":"Khan MA, Faisal SM, Nasti HT et al. Use of Tuftsin bearing nystatin liposomes against an isolate of C. albicans showing less in vivo susceptibility to amphotericin B. J Drug Target2003; 11: 93\u20139.","DOI":"10.1080\/1061186031000119093"},{"key":"key\n\t\t\t\t20171010172403_B12","doi-asserted-by":"crossref","unstructured":"Khan MA, Nasti TH, Khanam S et al. Coadministration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice. FEMS Immunol Med Microbiol2004; 41: 249\u201358.","DOI":"10.1016\/j.femsim.2004.03.011"},{"key":"key\n\t\t\t\t20171010172403_B13","doi-asserted-by":"crossref","unstructured":"Agarwal A, Kandpal H, Gupta HP et al. Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice. Antimicrob Agents Chemother1994; 38: 588\u201393.","DOI":"10.1128\/AAC.38.3.588"},{"key":"key\n\t\t\t\t20171010172403_B14","doi-asserted-by":"crossref","unstructured":"Agrawal AK, Agrawal A, Pal A et al. Superior chemotherapeutic efficacy of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters. J Drug Target2002; 10: 41\u20135.","DOI":"10.1080\/10611860290007513"},{"key":"key\n\t\t\t\t20171010172403_B15","doi-asserted-by":"crossref","unstructured":"Gupta CM, Puri A, Jain RK et al. Protection of mice against Plasmodium berghei infection by a tuftsin derivative. FEBS Lett1986; 205: 351\u20134.","DOI":"10.1016\/0014-5793(86)80927-9"},{"key":"key\n\t\t\t\t20171010172403_B16","doi-asserted-by":"crossref","unstructured":"Singleton WS, Gray MS, Brown ML. A method for adsorbent fractionation of cottonseed oil for experimental intravenous fat emulsions. J Am Oil Chem Soc1965; 42: 53\u20136.","DOI":"10.1007\/BF02558256"},{"key":"key\n\t\t\t\t20171010172403_B17","unstructured":"National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts: Approved Standard M-27A. NCCLS, Villanova, PA, USA, 1997."},{"key":"key\n\t\t\t\t20171010172403_B18","doi-asserted-by":"crossref","unstructured":"Murphy JW, Friedman H, Bendinelli M. Fungal Infections and Immune Responses. New York: Plenum Press, 1993.","DOI":"10.1007\/978-1-4899-2400-1"},{"key":"key\n\t\t\t\t20171010172403_B19","doi-asserted-by":"crossref","unstructured":"Chen WC, Chou DL, Feingold DS. Dissociation between ion permeability and the lethal action of polyene antibiotics on C. albicans. Antimicrob Agents Chemother1978; 13: 914\u20137.","DOI":"10.1128\/AAC.13.6.914"},{"key":"key\n\t\t\t\t20171010172403_B20","doi-asserted-by":"crossref","unstructured":"Dupont B. Overview of the lipid formulations of amphotericin B. J Antimicrob Chemother2002; 49 Suppl 1, 31\u20136.","DOI":"10.1093\/jac\/49.suppl_1.31"},{"key":"key\n\t\t\t\t20171010172403_B21","doi-asserted-by":"crossref","unstructured":"Owais M, Krishnakumar B, Jain RK et al. Tuftsin bearing liposomes as drug vehicles in the treatment of experimental aspergillosis. FEBS Lett1993; 326: 56\u20138.","DOI":"10.1016\/0014-5793(93)81760-W"},{"key":"key\n\t\t\t\t20171010172403_B22","doi-asserted-by":"crossref","unstructured":"Singhal A, Bali A, Jain RK et al. Specific interactions of liposomes with PMN leukocytes upon incorporating tuftsin in their bilayers. FEBS Lett1984; 178: 109\u201313.","DOI":"10.1016\/0014-5793(84)81251-X"},{"key":"key\n\t\t\t\t20171010172403_B23","doi-asserted-by":"crossref","unstructured":"Siemion, IZ, Kluczyk A. Tuftsin: On the 30-year anniversary of Victor Najjar's discovery. Peptides1999; 20: 645\u201374.","DOI":"10.1016\/S0196-9781(99)00019-4"},{"key":"key\n\t\t\t\t20171010172403_B24","doi-asserted-by":"crossref","unstructured":"Bauman SK, Huffnagle GB, Murphy JW. Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response. Infect Immun2003; 71: 68\u201374.","DOI":"10.1128\/IAI.71.1.68-74.2003"},{"key":"key\n\t\t\t\t20171010172403_B25","doi-asserted-by":"crossref","unstructured":"Cillari E, Arcoleo F, Dieli M et al. The macrophage-activating tetrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill Leishmania parasites in vitro. Infect Immun1994; 62: 2649\u201352.","DOI":"10.1128\/IAI.62.6.2649-2652.1994"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/56\/4\/726\/2308166\/dki307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T06:59:12Z","timestamp":1586415552000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/56\/4\/726\/769414\/Incorporation-of-amphotericin-B-in-tuftsinbearing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,26]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,8,26]]},"published-print":{"date-parts":[[2005,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki307","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,10]]},"published":{"date-parts":[[2005,8,26]]}}}